BioLogical Solutions Stockholm AB
ActiveKey figures
Key figures
2025Summary: BioLogical Solutions Stockholm AB
What kind of company is it?
BioLogical Solutions Stockholm AB (org. no. 559409-4822) is a limited company (AB). The company was registered in 2022 and has existed for 3 years. Registered seat: Bagarmossen. Industry according to Statistics Sweden: other research and experimental development on natural sciences and engineering (SNI 72109).
How is the company doing financially?
Net sales in financial year 2025 were 1 867 095 kr, up 44,4 % on the previous year (1 292 890 kr). From 2023 to 2025, net sales grew by an average of 34,8 % per year. Net profit for 2025 was 868 369 kr (46,5 % of net sales). The company was profitable in all 3 reported financial years. At the end of financial year 2025, total assets were 3 195 370 kr and equity 1 968 752 kr (equity ratio 61,6 %). The annual report for 2025 proposes a dividend of 300 000 kr.
Where does the data come from and how up to date is it?
Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by 2 people. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.
Dividend
from the annual reportProposed dividend 300 000 kr.
Summary of annual reports2023–2025
| 2023 | 2024 | 2025 | |
|---|---|---|---|
| Sales revenue | 1 027 831 | 1 292 890 | 1 867 095 |
| Profit for the reporting year | 571 831 | 703 552 | 868 369 |
| Retained earnings of previous periods | — | — | — |
| Total assets | 903 399 | 2 019 857 | 3 195 370 |
| Total liabilities | 306 568 | 719 474 | 1 226 618 |
| Total equity | 596 831 | 1 300 383 | 1 968 752 |
| Employees | — | — | — |
| Proposed dividend | 0 | 200 000 | 300 000 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.